Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Moderate Allocation ETF (AOM)

iShares Core Moderate Allocation ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AOM
DateTimeSourceHeadlineSymbolCompany
05/09/201212:22ZacksTarget Allocation ETF Investing 101 - ETF News And CommentaryAMEX:AOMiShares Core Moderate Allocation ETF
15/04/201213:50ZacksiShares Launches Multi-Asset, Global Junk Bond ETFs - ETF News And CommentaryAMEX:AOMiShares Core Moderate Allocation ETF
26/10/200615:00PR Newswire (US)Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical OfficerLSE:AOM
19/09/200613:30PR Newswire (US)Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and CondLSE:AOM
07/09/200623:11PR Newswire (US)AnorMED shares begin trading on NASDAQLSE:AOM
05/09/200615:38PR Newswire (US)AnorMED Board recommends shareholders reject hostile Genzyme offer and not tender sharesLSE:AOM
01/09/200623:41PR Newswire (US)AnorMED advises shareholders to take no action on unsolicited takeover bid from Genzyme CorporationLSE:AOM
30/08/200616:19PR Newswire (US)Genzyme to Initiate Tender Offer to Acquire AnorMED, Inc.LSE:AOM
30/08/200611:34PR Newswire (US)AnorMED rejects unsolicited approach from GenzymeLSE:AOM
28/08/200620:41PR Newswire (US)AnorMED announces NASDAQ listing and filing of shelf registration statementLSE:AOM
28/08/200615:00PR Newswire (US)AnorMED announces Annual and Special Meeting of ShareholdersLSE:AOM
27/07/200622:05PR Newswire (US)AnorMED reports fiscal 2007 first quarter results and upcoming milestonesLSE:AOM
20/06/200622:30PR Newswire (US)AnorMED to present at the Orion Healthcare ConferenceLSE:AOM
13/06/200622:05PR Newswire (US)AnorMED provides outlook for fiscal 2007LSE:AOM
09/06/200622:10PR Newswire (US)AnorMed to present at the fifth annual Needham Biotechnology ConferenceLSE:AOM
08/06/200622:10PR Newswire (US)AnorMED to present at the Pacific Growth Equities Life Sciences ConferenceLSE:AOM
03/06/200601:58PR Newswire (US)AnorMED announces departure of Vice President CommunicationsLSE:AOM
29/05/200623:31PR Newswire (US)AnorMED conference call notification - 4th Quarter Fiscal 2006 ResultsLSE:AOM
24/05/200609:10PR Newswire (US)AnorMED President and CEO Michael Abrams steps downLSE:AOM
21/04/200622:17PR Newswire (US)AnorMED Shareholders Vote Overwhelmingly For New Shareholder-Nominated BoardLSE:AOM
12/04/200619:58PR Newswire (US)Special Committee of AnorMED Board Rejects Compromise Slate of 7 MembersLSE:AOM
10/04/200603:51PR Newswire (US)Baker refuses previously agreed upon "hybrid" slateLSE:AOM
08/04/200601:58PR Newswire (US)AnorMED proposes to negotiate settlement with Baker via neutral third party mediatorLSE:AOM
07/04/200604:33PR Newswire (US)AnorMED dissidents fail to justify giving control of AnorMED to Baker GroupLSE:AOM
07/04/200600:40PR Newswire (US)AnorMED asks BC Supreme Court to order dissidents to correct information in proxy circularLSE:AOM
05/04/200617:59PR Newswire (US)AnorMED dissidents fail to justify giving control of AnorMED to Baker GroupLSE:AOM
01/04/200603:06PR Newswire (US)AnorMED to present at the CIBC World Markets Healthcare ConferenceLSE:AOM
27/03/200615:24PR Newswire (US)AnorMED conference call notification - AnorMED recommends shareholders reject dissident slate of director nomineesLSE:AOM
27/03/200615:06PR Newswire (US)AnorMED Recommends Shareholders Reject Dissident Slate of Director NomineesLSE:AOM
20/03/200613:15PR Newswire (US)AnorMED releases statement regarding rejection of the Baker Group proposal & decision to hold special shareholder meetingLSE:AOM
 Showing the most relevant articles for your search:AMEX:AOM